AMENDMENT NO. 1 TO EXECUTIVE SEVERANCE AGREEMENTExecutive Severance Agreement • February 23rd, 2024 • Teladoc Health, Inc. • Services-offices & clinics of doctors of medicine
This Amendment No. 1 to Executive Severance Agreement (this “Amendment”), by and between Teladoc Health, Inc., a Delaware corporation (“Teladoc” or the “Company”), and
EXECUTIVE SEVERANCE AGREEMENTExecutive Severance Agreement • February 23rd, 2024 • Teladoc Health, Inc. • Services-offices & clinics of doctors of medicine • New York
This Executive Severance Agreement ("Agreement") is made effective as of July 15, 2015 ("Effective Date"), by and between Teladoc, Inc. (the "Company") and Andrew Turitz ("Executive").
Teladoc Health, Inc. Letterhead]Separation and Release of Claims Agreement • February 23rd, 2024 • Teladoc Health, Inc. • Services-offices & clinics of doctors of medicine
As we have discussed, your employment with Teladoc Health, Inc. (the “Company”) as Chief Innovation Officer will terminate effective as of December 1, 2023 (“Termination Date”).
